Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2010
10/28/2010CA2757706A1 A novel cell and therapeutical and diagnostical methods based thereon
10/28/2010CA2754702A1 Selective ep4 receptor agonistic substance for treatment of cancer
10/28/2010CA2745596A1 Thiazolyl-benzimidazoles
10/27/2010EP2243833A1 Method for the treatment of acute myeloid leukemia
10/27/2010EP2243826A2 Mesenchymal stem cells and uses therefor
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243781A1 Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2243774A1 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
10/27/2010EP2243773A1 Platinum complex compound and utilization of the same
10/27/2010EP2243493A1 Immunopotentiative composition
10/27/2010EP2243492A1 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
10/27/2010EP2243491A1 Use of antagonist anti-CD40 monoclonal antibodies for treatment of chronic lymphocytic leukemia
10/27/2010EP2243480A1 Pharmaceutical formulations comprising oxaliplatin and an acid.
10/27/2010EP2242772A1 Immunoconjugates targeting cd138 and uses thereof
10/27/2010EP2242771A1 Binding molecules to the human ox40 receptor
10/27/2010EP2242770A2 Barb4 target which comprises tata-binding protein-associated factor 15, antibody designated barb4, barb4 related antibodies, and methods of making and using same
10/27/2010EP2242757A1 Pyrazolopyridines as kinase inhibitors
10/27/2010EP2242755A1 Pyrrolopyridines as kinase inhibitors
10/27/2010EP2242742A2 Organic compounds
10/27/2010EP2242514A2 Intralymphatic chemotherapy drug carriers
10/27/2010EP2242503A2 Therapeutic peptidomimetic macrocycles
10/27/2010EP2242493A1 Derivatives of gefitinib
10/27/2010EP2242492A1 Antitumoral agents with a benzophenanthridine structure and formulations containing them
10/27/2010EP1907399B1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
10/27/2010EP1830879B1 Mri guided photodynamic therapy for cancer
10/27/2010EP1537147B1 Antibody anti hla-dr with an increased adcc and inducing cytokine production
10/27/2010EP1487877B1 Compositions and methods for the diagnosis of tumors
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1385980B1 Yeast strains autonomously producing steroids
10/27/2010EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN201612864U 壳聚糖包覆药物缓释微球 Chitosan microspheres coated drug delivery
10/27/2010CN1993356B Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
10/27/2010CN1942583B Optimized expression of HPV 58 L1 in yeast
10/27/2010CN1918156B Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
10/27/2010CN1819996B Naphthylene derivatives as cytochrome P450 inhibitors
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN101874035A Novel sulfated oligosaccharide derivatives
10/27/2010CN101874034A Compounds and methods for the treatment of cancer
10/27/2010CN101873864A Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response
10/27/2010CN101873862A Composition and therapeutic anti-tumour vaccine
10/27/2010CN101870974A Preparation method of proteinase activated receptors agonist and use thereof
10/27/2010CN101870943A Brewing method and medicinal effect for special bamboo charcoal purification russula health wine
10/27/2010CN101870769A PEG (Polyethylene Glycol), mPEG (Methoxy Polyethylene Glycol) chemical modifier and method thereof for preparing water-soluble resveratrol prodrug
10/27/2010CN101870734A Fusogenic polypeptide for inhibiting neovascularization and coding gene and application thereof
10/27/2010CN101870726A Peptide - cisplatin conjugate and preparation method and application thereof
10/27/2010CN101870725A MAGE (Melanoma Antigen Gene)-4 anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof
10/27/2010CN101870724A PLAC1 (Placenta-specific 1) anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof
10/27/2010CN101870720A Preparation method of ursolic acid and application thereof to medicine treating tumor diseases
10/27/2010CN101870689A 3-(1-halogenated methylene) sulphur chromane-4-ketone compound as well as preparation method and application thereof
10/27/2010CN101870676A 1-(2-oximido-2-phenylethyl)-3-phenyl-1H-pyrazol-5-ethyl formate derivative as well as preparation method and application thereof
10/27/2010CN101869716A System for monitoring bacterial tumor treatment
10/27/2010CN101869712A Medicinal composition used for treating tumor by utilizing polymeric micelles of cyst anticancer drugs
10/27/2010CN101869707A Methods for enhancing innate and adaptive immunity and antigen immunogenicity
10/27/2010CN101869700A Chinese medicinal oral liquid for treating tumour and preparation method thereof
10/27/2010CN101869692A Curcumin self-microemulsion and preparation method thereof
10/27/2010CN101869688A Chinese medicinal compound preparation for treating uterine myoma
10/27/2010CN101869669A Chinese medicinal compound preparation for treating esophagus cancer
10/27/2010CN101869667A Chinese herbal medicinal composition for treating lung cancer
10/27/2010CN101869638A Traditional Chinese medicine for treating cancer and preparation method thereof
10/27/2010CN101869605A Method for extracting and separating mulberry leaf flavone and alkaloid composite
10/27/2010CN101869604A Preparation method and application of cortex meliae effective ingredients
10/27/2010CN101869591A Method for producing alkannin by utilizing Arnebia euchroma(Royle)Johnst hairy root
10/27/2010CN101869588A Preparation method and application of effective component of chrysanthemum
10/27/2010CN101869587A Method for extracting anti-gastric cancer active component from water chestnut shells
10/27/2010CN101869586A Extracting method of high-purity taxol and derivative thereof
10/27/2010CN101869575A Modulation of WRN-mediated telomere-initiated cell signaling
10/27/2010CN101869574A Application of uabain for enhancing cellular sensitivity of non-small cell lung cancer (NSCLC)
10/27/2010CN101869560A Isoalantolactone amino derivative and application of salt thereof in preparing anti-tumor medicament
10/27/2010CN101869558A Anti-angiogenesis and anti-metastasis effect of diacetyldianhydrogalactitol
10/27/2010CN101869557A Application of nordihydroguaiaretic acid in preparing drug capable of resisting tumour stem cells
10/27/2010CN101869551A Temozolomide freeze-dried preparation
10/27/2010CN101869172A Production method of active eel peptide
10/27/2010CN101239094B Active component composition used as adjuvant drug for antitumor and preparation and application thereof
10/27/2010CN101181232B Marseilledinun sustained-release implantation agent for curing entity tumour
10/27/2010CN101175738B Apoptosis promoters
10/27/2010CN101102773B Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases
10/27/2010CN101088521B Astragalus medicine prepn and its prepn process
10/27/2010CN101085216B Composition containing biological polysaccharide and biological polysaccharide wine made from the same
10/27/2010CN101052639B Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/27/2010CN101027309B Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer
10/26/2010USRE41895 Epothilone derivatives
10/26/2010USRE41893 Epothilone derivatives
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820807 can bind to and stimulate professional and non-professional human antigen-presenting cells, enhance the stimulatory effect of CD40L on CD40 positive cells and/or induce phenotypical maturation of monocyte derived dendritic cells
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820786 Synthetic peptides and uses therefore
10/26/2010US7820759 Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820719 exposing pancreatic cancer cell to a concentration of less than 100 mu g/ml of a drug substance selected from a product of polycondensation between a guanidine acid addition salt and a diamine compound comprising an oxyalkylene chain between two amino groups and a pharmaceutically acceptable salt thereof
10/26/2010US7820715 Chemical intermediates; neurodegenerative disorders
10/26/2010US7820714 Increased selectivity for sialic acid binding Ig-like lectins (Siglec); improving immune response dependent on B-cells
10/26/2010US7820713 Cocoa extracts as antioxidants
10/26/2010US7820697 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline; treatment of cancers, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, Crohn's disease and viral disease
10/26/2010US7820687 inflammatory diseases such as asthma, Alzheimer's disease, atherosclerosis, diabetes, autoimmune diseases, tumor metastasis and myocardial ischemia; improved bioavailability; 2-(2-(diethylamino)-5-(N-isopropylmethylsulfonamido)pyrimidin-4-ylamino)-3-(4-(pyrrolidine-1-carbonyloxy)phenyl)propanoic acid
10/26/2010US7820679 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
10/26/2010US7820658 such as 2-Amino-4-phenyl-thieno[2,3-d]pyrimidine-6-carboxylic acid ethylamide; veterinary medicine; anticancer agents
10/26/2010US7820646 Anticancer agents; antiproliferative agents; using an substituted aimidazole compound
10/26/2010US7820633 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte
1 ... 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 ... 2211